The Alterations of Metabolic Adipo-myokines and Body Composition in End Stage Lung Cancer

Launched by CHANG GUNG MEMORIAL HOSPITAL · Sep 24, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how changes in body composition and certain substances in the blood, known as adipo-myokines, relate to the effects of chemotherapy and the overall prognosis (outlook) for patients with advanced lung cancer. The researchers want to understand how these factors might affect patients' health and treatment outcomes as they undergo chemotherapy.

To participate in this trial, individuals need to be adults over 20 years old who have been diagnosed with stage III to stage IV lung cancer and have a daily performance status that allows them to engage in normal activities (rated between 0 and 2 on a scale). Unfortunately, people with cardiac stents or pacemakers are not eligible for this study. Participants can expect to be closely monitored throughout the trial, which will help researchers gather important information that may improve future treatments for lung cancer. The study is currently looking for volunteers to join.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Diagnosis of lung cancer stage III to stage IV
• • 2. Adults over 20 years old
• • 3. Daily performance status of 0- 2
• Exclusion Criteria:
• • 1. Cardiac stents or pacemakers